Richard A. Paulson

Director, President and CEO · 3 filings · Latest: May 13, 2026

Karyopharm Therapeutics Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
KPTI	Richard A. Paulson	Director, President and CEO	May 14, 2026	Sale	$9.50	2,203	$20.9K	269,747	May 15 8:03 PM
KPTI	Richard A. Paulson	Director, President and CEO	Mar 2, 2026	Sale	$9.41	12,361	$116.3K	267,030	Mar 3 9:21 PM